Chasing Novartis and Roche, Ventus banks $140M to take inflammatory disease drug into the clinic

Retrieved on: 2022-02-09 20:44:44

Tags for this article:

Click the tags to see associated articles and topics

Chasing Novartis and Roche, Ventus banks $140M to take inflammatory disease drug into the clinic. View article details on hiswai:

Excerpt

Again, the drug is in an area that a who's who of biopharma companies have targeted, and in some cases left, in recent years.

Article found on: www.fiercebiotech.com